R-CDOP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of rituximab, cyclophosphamide, liposomal doxorubicin, vincristine and prednisone (R-CDOP) that can be used in the treatment of some forms of non-Hodgkin lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL).

**Synonyms:** - R-CDOP - R-CDOP - R-CDOP (rituximab-abbs) - R-CDOP (rituximab-arrx) - R-CDOP (rituximab-blit) - R-CDOP (rituximab-pvvr) - R-CDOP (rituximab-rite) - R-CDOP (rituximab-rixa) - R-CDOP (rituximab-rixi) - RCDOP - Rituximab-Cyclophosphamide-Doxil-Oncovin-Prednisone Regimen - Rituximab-Cyclophosphamide-Liposomal Doxorubicin-Vincristine-Prednisone - Rituximab-Cyclophosphamide-Liposomal Doxorubicin-Vincristine-Prednisone Regimen - Rituximab/Cyclophosphamide/Doxil/Oncovin/Prednisone Regimen - Rituximab/Cyclophosphamide/Liposomal Doxorubicin/Vincristine/Prednisone - Rituximab/Cyclophosphamide/Liposomal Doxorubicin/Vincristine/Prednisone Regimen